GLP1-RA associated with PCSK9i as new therapy of anthracycline-induced cardiotoxicity under exposure to Ox-LDL: biochemical and preclinical evidences

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Cardio-oncology - diagnostic and therapeutic advances Cardio-Oncology HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by